Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals has disclosed Other Non Operating Income across 3 years of filings, most recently posting $169000.0 for Q4 2024.

• Other Non Operating Income for Q4 2024 came in at $169000.0, up 121.13% year-over-year; the trailing twelve-month figure through Dec 2024 was $169000.0 (changed N/A YoY), and the FY2025 annual result was $389000.0, up 130.18% from the prior year.
• Other Non Operating Income came in at $169000.0 for Q4 2024 at Eton Pharmaceuticals, up from -$800000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $800000.0 in Q2 2023 to a low of -$800000.0 in Q4 2023.
• The 3-year median for Other Non Operating Income is $267000.0 (2021), against an average of $133500.0.
• Peak annual rise in Other Non Operating Income reached 121.13% in 2024, while the deepest fall reached 121.13% in 2024.
• Eton Pharmaceuticals' Other Non Operating Income stood at $365000.0 in 2021, then tumbled by 319.18% to -$800000.0 in 2023, then jumped by 121.12% to $169000.0 in 2024.
• The last three Other Non Operating Income figures came in at $169000.0 (Q4 2024), -$800000.0 (Q4 2023), and $800000.0 (Q2 2023), per Business Quant data.